Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer S Romer-Seibert

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Hematology|November 13, 2020
Genetic heterogeneity and clonal evolution in acute myeloid leukemiaJennifer S Romer-Seibert, Sara E Meyer
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 14, 2018
The RNA-binding protein LIN28 controls progenitor and neuronal cell fate during postnatal neurogenesisJennifer S Romer-Seibert, Nathaniel W Hartman, Eric G Moss
Leukemia|November 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesisMichael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert, et al.
Blood Advances|August 20, 2025
TLR2 Agonism Suppresses Myeloid Leukemogenesis by Reprogramming Leukemia Stem CellsMichael E Lawler, Jennifer S Romer-Seibert, Michael S Bowman, et al.
Science Advances|May 15, 2026
P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AMLMelanie L Goetz, Jennifer S Romer-Seibert, Amanda M Versace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AMLHolly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Hematology|November 13, 2020
Genetic heterogeneity and clonal evolution in acute myeloid leukemiaJennifer S Romer-Seibert, Sara E Meyer
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 14, 2018
The RNA-binding protein LIN28 controls progenitor and neuronal cell fate during postnatal neurogenesisJennifer S Romer-Seibert, Nathaniel W Hartman, Eric G Moss
Leukemia|November 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesisMichael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert, et al.
Blood Advances|August 20, 2025
TLR2 Agonism Suppresses Myeloid Leukemogenesis by Reprogramming Leukemia Stem CellsMichael E Lawler, Jennifer S Romer-Seibert, Michael S Bowman, et al.
Science Advances|May 15, 2026
P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AMLMelanie L Goetz, Jennifer S Romer-Seibert, Amanda M Versace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AMLHolly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler, et al.
Pageof 1